What's breaking now, across thousands of outlets.
For the pharmaceutical division, US approval is crucial: its bestseller Xarelto is losing sales. Asundexian is intended to fill the gap - especially in the US, where Bayer is growing the fastest.
We haven't written up this one. Handelsblatt has the full story — the link below goes straight to it.
British drugmaker GSK has settled lawsuits that accused Moderna’s COVID-19 vaccines Spikevax and mNEXSPIKE and RSV shot mResvia of infringing its patents, the companies said on Oct. 6.
WESTERN BUREAU: The family of 36-year-old Rushelle Gordon, of Hendon, Norwood, in St James, is seeking the public’s assistance to find her after she went missing in Montego Bay last Thursday.
US regulators say the rare eye condition NAION can cause permanent vision loss. All GLP-1 drugs, including Ozempic and Wegovy, will now carry the warning.
[SNA] Port Sudan (SUNA) - Red Sea State Wali Lt. Gen. Mustafa Mohamed Nour on Monday chaired the second meeting of the State Health Insurance Financing Council, attended by a number of executive…
Joan McConville is calling for a national screening programme in Northern Ireland, like there is in England and Wales.
THE World Health Organisation (WHO) has urged continued diagnostic testing as a newly emerging COVID-19 variant, PJ.2.1, spreads internationally with symptoms that can be mistaken for influenza or the…
